Description
RADIOPHARMACEUTICAL - OY2 DEOB EXCESS FUNDS
Base award description: RADIOPHARMACEUTICAL DELIVERIES
Modification chain · 22 transactions
Each row is one published transaction. This action is the obligation recorded on that transaction — a change amount, as USAspending publishes it. Running total is computed by Glassbox VA as the cumulative sum of those amounts up to and including the row, so the last running total equals the award's net obligations shown above. The cumulative-total columns in the source files are not used: they are not frozen per modification.
- Base2019-05-03+$116,455= $116,455
- Mod P000012020-04-10+$119,370= $235,825
- Mod P000032020-04-10+$36,580= $272,405
- Mod P000022020-05-04+$4,572= $276,977
- Mod P000042020-08-27-$67,245= $209,732
- Mod P000052021-03-25+$162,188= $371,919
- Mod P000062021-04-21+$3,465= $375,384
- Mod P000072021-05-04+$1,486= $376,870
- Mod P000082021-05-19+$3,465= $380,335
- Mod P000092021-12-28-$70,617= $309,718
- Mod P000102022-02-10+$162,729= $472,447
- Mod P000112022-04-19+$15,211= $487,658
- Mod P000122022-06-02+$15,211= $502,869
- Mod P000132022-08-24-$106,239= $396,631
- Mod P000142023-02-14+$165,355= $561,985
- Mod P000152023-02-16+$0= $561,985
- Mod P000162023-03-13+$809= $562,794
- Mod P000172023-03-15+$809= $563,603
- Mod P000182023-05-10-$15,211= $548,392
- Mod P000192023-12-18-$100,488= $447,904
- Mod P000202024-04-25-$22,259= $425,645
- Mod P000212024-07-23-$134,632= $291,013
| Transaction | Action date | This action (delta) | Running total | Description on this transaction |
|---|---|---|---|---|
| Base | 2019-05-03 | +$116,455 | $116,455 | RADIOPHARMACEUTICAL DELIVERIES |
| Mod P00001· EXERCISE AN OPTION | 2020-04-10 | +$119,370 | $235,825 | RADIOPHARMACEUTICAL |
| Mod P00003· EXERCISE AN OPTION | 2020-04-10 | +$36,580 | $272,405 | RADIOPHARMACEUTICAL |
| Mod P00002· OTHER ADMINISTRATIVE ACTION | 2020-05-04 | +$4,572 | $276,977 | RADIOPHARMACEUTICAL |
| Mod P00004· OTHER ADMINISTRATIVE ACTION | 2020-08-27 | −$67,245 | $209,732 | RADIOPHARMACEUTICAL |
| Mod P00005· EXERCISE AN OPTION | 2021-03-25 | +$162,188 | $371,919 | RADIOPHARMACEUTICAL |
| Mod P00006· OTHER ADMINISTRATIVE ACTION | 2021-04-21 | +$3,465 | $375,384 | RADIOPHARMACEUTICAL |
| Mod P00007· OTHER ADMINISTRATIVE ACTION | 2021-05-04 | +$1,486 | $376,870 | RADIOPHARMACEUTICAL |
| Mod P00008· OTHER ADMINISTRATIVE ACTION | 2021-05-19 | +$3,465 | $380,335 | RADIOPHARMACEUTICAL |
| Mod P00009· OTHER ADMINISTRATIVE ACTION | 2021-12-28 | −$70,617 | $309,718 | RADIOPHARMACEUTICAL - DE-OBLIGATION OF EXCESS FUNDS FROM OY1 |
| Mod P00010· EXERCISE AN OPTION | 2022-02-10 | +$162,729 | $472,447 | RADIOPHARMACEUTICAL - OY3 |
| Mod P00011· SUPPLEMENTAL AGREEMENT FOR WORK WITHIN SCOPE | 2022-04-19 | +$15,211 | $487,658 | RADIOPHARMACEUTICAL - OY2 QUANTITY INCREASE |
| Mod P00012· SUPPLEMENTAL AGREEMENT FOR WORK WITHIN SCOPE | 2022-06-02 | +$15,211 | $502,869 | RADIOPHARMACEUTICAL - OY3 QUANTITY INCREASE |
| Mod P00013· OTHER ADMINISTRATIVE ACTION | 2022-08-24 | −$106,239 | $396,631 | RADIOPHARMACEUTICAL - OY2 DEOB EXCESS FUNDS |
| Mod P00014· EXERCISE AN OPTION | 2023-02-14 | +$165,355 | $561,985 | RADIOPHARMACEUTICAL - OY2 DEOB EXCESS FUNDS |
| Mod P00015· OTHER ADMINISTRATIVE ACTION | 2023-02-16 | +$0 | $561,985 | RADIOPHARMACEUTICAL - OY2 DEOB EXCESS FUNDS |
| Mod P00016· FUNDING ONLY ACTION | 2023-03-13 | +$809 | $562,794 | RADIOPHARMACEUTICAL - OY2 DEOB EXCESS FUNDS |
| Mod P00017· FUNDING ONLY ACTION | 2023-03-15 | +$809 | $563,603 | RADIOPHARMACEUTICAL - OY2 DEOB EXCESS FUNDS |
| Mod P00018· FUNDING ONLY ACTION | 2023-05-10 | −$15,211 | $548,392 | RADIOPHARMACEUTICAL - OY2 DEOB EXCESS FUNDS |
| Mod P00019· FUNDING ONLY ACTION | 2023-12-18 | −$100,488 | $447,904 | RADIOPHARMACEUTICAL - OY2 DEOB EXCESS FUNDS |
| Mod P00020· FUNDING ONLY ACTION | 2024-04-25 | −$22,259 | $425,645 | RADIOPHARMACEUTICAL - OY2 DEOB EXCESS FUNDS |
| Mod P00021· FUNDING ONLY ACTION | 2024-07-23 | −$134,632 | $291,013 | RADIOPHARMACEUTICAL - OY2 DEOB EXCESS FUNDS |
Related awards · 11
Awards are related by an explicit link in the data, stated for each group below — never by text similarity. Values are net obligations.
Other VA awards to the same recipient (UEI EQ4VSLH8RC33)
| Award | Office · PSC / listing | Net obligations | FY |
|---|---|---|---|
| 36C24826N0411 | 248-NETWORK CONTRACT OFFICE 8 (36C248) · 6505 · DRUGS AND BIOLOGICALS | $231,773 | FY2026 |
| 36C24126N0274 | 241-NETWORK CONTRACT OFFICE 01 (36C241) · 6505 · DRUGS AND BIOLOGICALS | $771,411 | FY2026 |
| 36C25226N0210 | 252-NETWORK CONTRACT OFFICE 12 (36C252) · 6505 · DRUGS AND BIOLOGICALS | $164,999 | FY2026 |
| 36C26126N0065 | 261-NETWORK CONTRACT OFFICE 21 (36C261) · 6505 · DRUGS AND BIOLOGICALS | $153,991 | FY2026 |
| 36C24825N0208 | 248-NETWORK CONTRACT OFFICE 8 (36C248) · 6505 · DRUGS AND BIOLOGICALS | $224,563 | FY2025 |
| 36C24125N0495 | 241-NETWORK CONTRACT OFFICE 01 (36C241) · 6505 · DRUGS AND BIOLOGICALS | $656,883 | FY2025 |
Other recipients under Q527 from 247-NETWORK CONTRACT OFFICE 7 (36C247) (most recent first)
| Award | Recipient | Office | Net obligations | FY |
|---|---|---|---|---|
| 36C24726P0726 | PETNET SOLUTIONS, INC. | 247-NETWORK CONTRACT OFFICE 7 (36C247) | $1,575,677 | FY2026 |
| 36C24726P0672 | JUBILANT DRAXIMAGE RADIOPHARMACIES, INC. | 247-NETWORK CONTRACT OFFICE 7 (36C247) | $112,908 | FY2026 |
| 36C24726P0659 | TRILLAMED LLC | 247-NETWORK CONTRACT OFFICE 7 (36C247) | $261,598 | FY2026 |
| 36C24726C0041 | PETNET SOLUTIONS, INC. | 247-NETWORK CONTRACT OFFICE 7 (36C247) | $288,295 | FY2026 |
| 36C24725P1135 | CARDINAL HEALTH 414, LLC | 247-NETWORK CONTRACT OFFICE 7 (36C247) | $167,038 | FY2025 |
Cite as: Glassbox VA record view · VA contract (USAspending / FPDS) · CONT_AWD_36C24719P0682_3600_-NONE-_-NONE- · retrieved 2026-09-27.